UK – NICE plans to widen the net for data it uses in guidance

UK cost-effectiveness body NICE has said it intends to use a broader range of data and analytics in the formulation of its guidance, including electronic health records and real-world evidence.

The plan – originally proposed in principle last month – has now been formally adopted, with NICE saying yesterday that it will now “update our processes and methods for the identification, assessment and interpretation of data”.

Health Secretary Matt Hancock has acknowledged that NICE and other regulatory agencies have a duty to ensure that their “rules, processes and ways of working” are up to date, and NICE itself has said it needs to make sure it adapts to handle new types of medicines like ‘histology independent’ cancer drugs…